Peter Georgiev
@_petergeorgiev_
PhD Student @Harvard_Imm @HaigisLab | #Immunobiology + #Metabolism Enthusiast | #Fishing Guru | #girldad | Previously @Merck @BostonChildrens
ID: 1575648861405978624
https://immunologyphd.hms.harvard.edu/people/peter-georgiev 30-09-2022 00:49:04
32 Tweet
101 Followers
321 Following
Excited to share our co-first authored paper with Peter Georgiev. Thank you @HaigisLab, Arlene and Alison E Ringel for mentorship, guidance and support! A MUST read for anyone interested in aging, metabolism and immunity! Harvard Medical School @HarvardCellBio Harvard Immunology Cell Metabolism
A new Review summarizes current challenges facing CAR T cell immunotherapy, examines #cancer cells’ metabolic adaptations, and identifies potential metabolic interventions to enhance CAR T cell efficacy. Oncology UNIL CHUV Université de Lausanne Learn more: scim.ag/2iS
I am excited to share our collaborative regulatory T cell review between the @HaigisLab, Sharpe and Chatila laboratories now out Journal of Allergy and Clinical Immunology. I feel fortunate to have worked with Mehdi Benamar, PhD James SeongJun Han, PhD and a terrific mentoring team for this piece. jacionline.org/article/S0091-…
Check out our collaborative Treg review now in print Journal of Allergy and Clinical Immunology. Mehdi Benamar, PhD James SeongJun Han, PhD @HaigisLab Regulatory T cells in dominant immunologic tolerance - Journal of Allergy and Clinical Immunology jacionline.org/article/S0091-…
I think only we get this excited for EAE takedowns in the Sharpe lab! Harvard Immunology
Had alot of fun talking science at the KGCRF poster competition Harvard Medical School Harvard Immunology Landry Cancer Biology Consortium
Thrilled to share our study on anti-tumor immunity during aging with James SeongJun Han, PhD Alison E Ringel @HaigisLab. Here we demonstrate that the loss of tumor-reactive CD8+ T cells is a cardinal feature that accelerates tumor outgrowth in aged mice and promotes resistance to immune
Excited to share our manuscript outlining the impact of aging on anti-tumor CD8+ T cell response Cancer Immunology Research! Special thanks to my partner-in-bench Peter Georgiev, Alison E Ringel for guidance and collaboration, Arlene and @HaigisLab for mentorship and all the co-authors!
Excited to announce I am starting as an Assistant Professor of Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine Miller Medicine Honored to join the amazing teams Sylvester Comprehensive Cancer Center and the Frost Institute for Chemistry and Molecular Science
Georgiev and Han et al. recently identified age-related changes in the immune system that contribute to increased cancer progression and reduced responsiveness to immunotherapy bit.ly/3zhT77T Peter Georgiev Alison E Ringel Ragon Institute
Nice little digest of our recent work with James SeongJun Han, PhD Alison E Ringel @HaigisLab Age is more than just a number in cancer immunotherapy acir.org/weekly-digests…
Super excited for Lydia Lynch talk at the inaugural I&I seminar series at NYU Langone Health. One of my favorite #GdTcell Rockstars, though today teaching us about diets:: TME.
.Ragon Institute's Alison E Ringel has uncovered how aging impairs the immune system’s ability to fight cancer. She showed that as the body ages, a type of immune cells called CD8+ T cells become less effective. 📝 Cancer Immunology Research: bit.ly/3ZUvNYX 📰 bit.ly/4dE1SHJ
